Novo Nordisk weight-loss drug wins US approval as a daily pill
Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind
Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
